Search results for "ovary"

showing 10 items of 341 documents

Optimization of Cell Growth on Bacterial Cellulose by Adsorption of Collagen and Poly-L-Lysine

2015

Poly-L-lysine and collagen were separately added to bacterial cellulose (BC) nanofibers. The ionic surface charge had been previously modified in order to promote the adsorption of poly-L-lysine and collagen. Cell adhesion of Chinese hamster ovary (CHO) cells on BC surfaces was confirmed by removing unattached cells from the BC substrates. Cell viability was calculated and it was determined that both poly-L-lysine-BC and collagen-BC substrates are viable for cell growth. The results showed that the cell viability in poly-L-lysine modified BC substrate is similar to the one observed in polystyrene tissue culture plates.

Materials sciencePolymers and PlasticsCell growthGeneral Chemical EngineeringChinese hamster ovary cellSubstrate (chemistry)complex mixturesAnalytical Chemistrychemistry.chemical_compoundTissue cultureAdsorptionchemistryBiochemistryBacterial celluloseBiophysicsbacteriaViability assayCell adhesionInternational Journal of Polymeric Materials and Polymeric Biomaterials
researchProduct

Protein synthesis in developing ovaries of mealworm under in vivo and in vitro conditions: Effects of diflubenzuron

1996

Abstract The effect of diflubenzuron (DFB) on protein synthesis in the ovaries of Tenebrio molitor was evaluated during oocyte maturation using in vivo and in vitro assays. When incorporated into the diet (5 and 10 mg g −1 ), DFB was found to affect both the weight, the protein levels and the incorporation of tritiated leucine into proteins of ovaries. In addition, electrophoretic separation of ovarian proteins by sodium dodecyl sulfate-polyacrylamide slab gels (SDS-PAGE) showed that DFB applied in vivo did not have a significant effect on the number of protein bands. When added to the culture medium (5 and 10 μg ml −1 ), DFB resulted in a slight but significant decrease in the rate of inco…

MealwormbiologySodiumchemistry.chemical_elementOvaryHorticulturebiology.organism_classificationIn vitrochemistry.chemical_compoundDiflubenzuronmedicine.anatomical_structurechemistryBiochemistryIn vivoInsect SciencemedicineProtein biosynthesisLeucineAgronomy and Crop ScienceFood ScienceJournal of Stored Products Research
researchProduct

Expression of Muscarinic Receptor Types in the Primate Ovary and Evidence for Nonneuronal Acetylcholine Synthesis1

2001

The presence of muscarinic receptors (MR) in the ovary of different species has been recognized, but the identity of these receptors as well as ovarian sources of their natural ligand, acetylcholine (ACh), have not been determined. Because luteinized human granulosa cells (GC) in culture express functional MR, we have determined whether the group of the related MR subtypes, M1R, M3R, and M5R, are present in vivo in human and rhesus monkey ovaries. To this end, ribonucleic acids (RNAs) of different human and monkey ovaries as well as RNAs from human GC and monkey oocytes were reverse transcribed and subjected to PCR amplification, followed by sequencing of the amplified complementary DNAs. R…

Messenger RNAmedicine.medical_specialtyEndocrinology Diabetes and MetabolismGranulosa cellBiochemistry (medical)Clinical BiochemistryOvaryBiologyBiochemistryCholine acetyltransferaseMolecular biologyEndocrinologymedicine.anatomical_structureEndocrinologyInternal medicineMuscarinic acetylcholine receptormedicineReceptorAcetylcholinemedicine.drugAcetylcholine receptorThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Cloning and functional analysis of cDNA encoding the hamster Bcl-2 protein.

2000

We have cloned cDNA encoding hamster Bcl-2 protein from total RNA of CHO-9 cells by RT-PCR using oligonucleotide primers sharing homology with the sequence of mouse and rat bcl-2. The fragments spanning the total coding region were cloned into pCR4-TOPO and sequenced for verification. The hamster bcl-2 cDNA has a size of 711 nucleotides and encodes a polypeptide of 236 amino acids. Hamster Bcl-2 shares 95.8 and 88.6% similarity with mouse and human Bcl-2, respectively. Northern blot analysis revealed a single 7.5 kb bcl-2 transcript in hamster (CHO-9), mouse (BK4), and rat (H5) cells and a 8.5 kb bcl-2 mRNA in human (HeLa MR) cells. The bcl-2 cDNA (771 bp) was recloned into pcDNA3 and the r…

MethylnitronitrosoguanidineDNA ComplementaryAlkylationMolecular Sequence DataBiophysicsHamsterBiologyTransfectionBiochemistryCell LineComplementary DNACricetinaeCoding regionAnimalsHumansNorthern blotAmino Acid SequenceRNA MessengerCloning MolecularMolecular BiologyCloningMessenger RNABase SequenceCell DeathSequence Homology Amino AcidChinese hamster ovary cellCell BiologyTransfectionMolecular biologyProto-Oncogene Proteins c-bcl-2CarcinogensSequence AlignmentBiochemical and biophysical research communications
researchProduct

Testis asymmetry in birds: the influences of sexual and natural selection

2014

Gonad size and shape asymmetries are particularly common in birds. Although some obvious size and shape differences between the left and right testes in birds were first documented more than a century ago, little is known about what influences the variation across species in either the degree or the direction of these asymmetries. Here we show that a left bias in size is the most likely ancestral state in most orders and families, and that there is a weak but significant negative relation between the degree of size and shape asymmetries. In extant species, testis size and shape symmetries increase with the degree of sperm competition (relative testes mass), but those relations are significa…

Natural selectionGonadOvary (botany)Zoologynatural selectionAnatomyBiologyLeft Testismedicine.anatomical_structurebirdsmedicineSeasonal breederta1181sexual selectionAnimal Science and Zoologytestis asymmetryGizzardBody cavitySperm competitionEcology Evolution Behavior and SystematicsJournal of Avian Biology
researchProduct

Need for liver evaluation in polycystic ovary syndrome

2007

Medicine is changing and requires a more in-depth knowledge also in fields that were previously considered completely different and dedicated to other specialists. A good example of this general trend is the paper by Cerda et al. [1] that shows a high prevalence of nonalcoholic fatty liver disease (NAFLD) in women with Polycystic Ovary Syndrome (PCOS). The authors studied 41 young women with PCOS and found that 17 patients (41%) had NAFLD. In addition, 7 patients with NAFLD had increased aminotransferase levels raising the possibility of a transition to nonalcoholic steatohepatitis (NASH). Other reports have shown similar data recently [2–5]. It is time therefore that doctors caring for pat…

Nonalcoholic steatohepatitisMetabolic Syndromemedicine.medical_specialtySettore MED/12 - GastroenterologiaSettore MED/09 - Medicina InternaHepatologyPCOS Liver function NASH NAFLDbusiness.industrynutritional and metabolic diseasesmedicine.diseaseGastroenterologyPolycystic ovarySettore MED/13 - EndocrinologiaFatty LiverLiver Function TestsInternal medicineNonalcoholic fatty liver diseasePrevalenceMedicineHumansFemalebusinessPolycystic Ovary Syndrome
researchProduct

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcome…

2016

Purpose The Suppression of Ovarian Function trial showed improved disease control for tamoxifen plus ovarian function suppression (OFS) compared with tamoxifen alone for the cohort of premenopausal patients who received prior chemotherapy. We present the patient-reported outcomes. Patients and Methods The quality-of-life (QoL) analysis includes 1,722 of 2,045 premenopausal patients with hormone receptor–positive breast cancer randomly assigned to receive adjuvant treatment with 5 years of tamoxifen plus OFS or tamoxifen alone. Chemotherapy use before enrollment was optional. Patients completed a QoL form consisting of global and symptom indicators at baseline, every 6 months for 24 months, …

OncologyAdultCancer Researchmedicine.medical_specialtymedicine.medical_treatmentOvaryBreast Neoplasmslaw.invention03 medical and health sciences0302 clinical medicineBreast cancerRandomized controlled trialQuality of lifelawInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumans030212 general & internal medicineChemotherapyTriptorelin Pamoatebusiness.industryOvaryRepeated measures designORIGINAL REPORTSmedicine.diseaseAndrostadienesTamoxifenmedicine.anatomical_structureOncologyPremenopauseChemotherapy Adjuvant030220 oncology & carcinogenesisLymphatic MetastasisCohortQuality of LifeFemaleSelf ReportbusinessTamoxifenmedicine.drug
researchProduct

Abstract 1832: Associations between ovarian cancer and other malignant neoplasms in an international population-based study

2010

Abstract Recent studies have suggested that different histological types of ovarian cancer develop via different pathways. Large epidemiological studies of first and second malignant neoplasms associated with ovarian cancer can quantify such risk and may provide etiologic clues in understanding these complex pathways. We analyzed ovarian cancer data from 13 different cancer registries in Europe, Australia, Canada and Singapore from 1943-2000. Cumulative risks were calculated using a competing risk model, and standardized incidence ratios (SIR) for 34 cancers were estimated based on the observed numbers of second malignancies and the expected numbers obtained from population-specific inciden…

OncologyCancer Researchmedicine.medical_specialtyBladder cancerbusiness.industrySoft tissue sarcomaRectumCancerOvarymedicine.diseaseSerous fluidmedicine.anatomical_structureBreast cancerOncologyInternal medicineMedicinebusinessOvarian cancerCancer Research
researchProduct

New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients

2015

Objective To develop a novel molecular panel of markers to detect breast cancer (BC) disseminated malignant cells in ovarian tissue, and to improve the safety of ovarian tissue transplantation. Design Experimental study. Setting University hospital. Patient(s) Ten ovarian biopsies from healthy patients, 13 biopsies with diagnosed BC metastasis, and 4 biopsies from primary BC tumor for designing a diagnostic panel of BC cell contamination; 60 ovarian biopsies from BC patients undergoing fertility preservation for validating the panel. Animal(s) Female nude mice. Intervention(s) A novel panel for BC malignant cell detection by reverse-transcription polymerase chain reaction (RT-PCR), inmmunoh…

OncologyPathologyBiopsyMetastasisPregnancyRisk FactorsMedicineOvarian tissue cryopreservationFertility preservationMUC1Ovarian Neoplasmsmedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionMammaglobin AFertility PreservationObstetrics and GynecologyMiddle AgedImmunohistochemistrymedicine.anatomical_structureNeoplasm MicrometastasisHeterograftsFemaleInfertility FemaleAdultmedicine.medical_specialtyReproductive Techniques AssistedMice NudeBreast NeoplasmsOvaryBreast cancerPredictive Value of TestsInternal medicineBiopsyBiomarkers TumorAnimalsHumansNeoplasm InvasivenessAgedGlycoproteinsCryopreservationbusiness.industryOvaryMucinsMembrane Transport ProteinsReproducibility of Resultsmedicine.diseaseTransplantationFertilityReproductive MedicineCase-Control StudiesCarrier ProteinsbusinessFertility and Sterility
researchProduct

What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?

2012

Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose to familial breast and/or ovarian cancer. The lifetime risk of members of families with genetic predisposition depends on the mutations of susceptibility genes. BRCA1 mutations seem to confer the highest risk of developing neoplastic diseases. Apart from breast and ovarian cancer mutations in BRCA, related pathways are supposed to confer a smaller risk for additional cancers (colon, melanoma, pancreas, lymphoma, prostate, liver). All these tumors have an inherited component not necessarily associated with genetic susceptibility to BRCA genes. To date he main focus of this review has been argued still with difficulty…

Oncologymedicine.medical_specialtybusiness.industrySettore MED/06 - Oncologia MedicaObstetrics and GynecologyCancerOvarymedicine.diseasemedicine.anatomical_structureInternal medicinemedicineCancer riskbusinessBRCA genes BRCA mutations cancer risk.Brca genes
researchProduct